Header cover image

Materials Healthcare Sector

Results

2302

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2302 companies

Helix BioPharma

Market Cap: CA$50.4m

Operates as an immune-oncology company in Canada.

HBP

CA$0.92

7D

-3.2%

1Y

-10.2%

Futura Medical

Market Cap: UK£26.9m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

FUM

UK£0.088

7D

-0.7%

1Y

-76.8%

Poolbeg Pharma

Market Cap: UK£26.8m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

POLB

UK£0.038

7D

48.1%

1Y

-70.7%

Renalytix

Market Cap: UK£26.5m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

RENX

UK£0.08

7D

-5.9%

1Y

-57.9%

Retrieve Medical Holdings

Market Cap: US$35.5m

Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.

RMHI

US$1.50

7D

-40.0%

1Y

-62.5%

Rani Therapeutics Holdings

Market Cap: US$35.5m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

RANI

US$0.62

7D

-17.1%

1Y

-86.5%

Lantern Pharma

Market Cap: US$35.5m

Focuses on the discovery and development of oncology drug.

LTRN

US$2.90

7D

-16.7%

1Y

-53.1%

AN2 Therapeutics

Market Cap: US$35.3m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

ANTX

US$1.18

7D

-0.8%

1Y

-44.3%

Pluri

Market Cap: US$35.1m

A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.

PLUR

US$4.55

7D

-6.6%

1Y

-31.1%

Burning Rock Biotech

Market Cap: US$35.0m

Primarily develops and sells cancer therapy selection tests in the People's Republic of China.

BNR

US$3.29

7D

13.1%

1Y

-56.4%

Quantum BioPharma

Market Cap: CA$48.2m

Operates as a biopharmaceutical company.

QNTM

CA$15.90

7D

0.3%

1Y

-48.0%

Propanc Biopharma

Market Cap: US$34.8m

A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

PPCB

US$3.15

7D

26.5%

1Y

-95.6%

Envoy Medical

Market Cap: US$34.8m

A hearing health company, focuses on providing medical technologies across the hearing loss spectrum.

COCH

US$1.56

7D

-9.3%

1Y

-40.5%

Microbix Biosystems

Market Cap: CA$47.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

MBX

CA$0.34

7D

1.5%

1Y

6.2%

Rafael Holdings

Market Cap: US$34.6m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.

RFL

US$1.30

7D

-4.4%

1Y

-17.2%

MedAdvisor

Market Cap: AU$53.7m

Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.

MDR

AU$0.086

7D

-2.3%

1Y

-80.2%

Light AI

Market Cap: CA$47.9m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

ALGO

CA$0.40

7D

23.4%

1Y

n/a

Proteomics International Laboratories

Market Cap: AU$53.7m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.

PIQ

AU$0.41

7D

3.8%

1Y

-58.2%

Boundless Bio

Market Cap: US$34.5m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

BOLD

US$1.30

7D

-21.7%

1Y

-86.5%

Shield Therapeutics

Market Cap: UK£25.5m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

STX

UK£0.025

7D

2.1%

1Y

4.3%

Golden Valley Development

Market Cap: US$34.2m

Through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors.

GVDI

US$0.05

7D

0%

1Y

400.0%

Reliq Health Technologies

Market Cap: CA$47.3m

A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.

RHT

CA$0.21

7D

0%

1Y

-57.0%

Defence Therapeutics

Market Cap: CA$47.1m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

DTC

CA$0.87

7D

-4.4%

1Y

-24.3%

Ocumetics Technology

Market Cap: CA$46.7m

Engages in research, development, production, and sale of vision enhancement products in Canada.

OTC

CA$0.39

7D

8.3%

1Y

30.0%

LAVA Therapeutics

Market Cap: US$33.7m

Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.

LVTX

US$1.29

7D

-2.3%

1Y

-46.0%

Aligos Therapeutics

Market Cap: US$33.6m

A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.

ALGS

US$5.59

7D

-7.8%

1Y

-63.5%

Rockwell Medical

Market Cap: US$33.5m

Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.

RMTI

US$0.96

7D

-10.0%

1Y

-46.2%

Compumedics

Market Cap: AU$51.9m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.

CMP

AU$0.27

7D

-10.0%

1Y

14.9%

FibroGen

Market Cap: US$33.3m

A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.

FGEN

US$0.32

7D

-6.6%

1Y

-74.9%

Precision Optics Corporation

Market Cap: US$33.2m

Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

POCI

US$4.66

7D

6.6%

1Y

-29.1%

MTL Cannabis

Market Cap: CA$45.6m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

MTLC

CA$0.37

7D

15.6%

1Y

25.4%

Abingdon Health

Market Cap: UK£24.4m

Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.

ABDX

UK£0.065

7D

6.6%

1Y

-40.9%

KDA Group

Market Cap: CA$45.3m

Provides technological solutions to general and specialized health sectors in Canada.

KDA

CA$0.24

7D

-5.8%

1Y

-35.5%

Tryptamine Therapeutics

Market Cap: AU$50.4m

A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.

TYP

AU$0.035

7D

-5.4%

1Y

n/a

Theralase Technologies

Market Cap: CA$44.8m

A clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally.

TLT

CA$0.17

7D

-2.8%

1Y

6.1%

Cyclacel Pharmaceuticals

Market Cap: US$32.3m

A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.

CYCC

US$1.62

7D

-7.4%

1Y

-95.0%

Page 29 of 64